The report "Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027", is projected to reach USD 5.4 billion by 2027 from USD 2.9 billion in 2022 growing at a CAGR of 13.3%. Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market.
Browse 347 market data Tables and 47 Figures spread through 327 Pages and in-depth TOC on "Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html
The Mammalian expression system segment accounted for the largest share in the Protein Expression Market, by system type, during the forecast period.
Based on system type, the protein expression market is segmented into mammalian cell expression systems, prokaryotic expression systems, insect cell expression systems, yeast expression systems, cell-free expression systems, and algal-based expression systems. The large share of this segment can be owed to the low cost and ease of use of mammalian cell expression systems.
The Research applications subsegment accounted for the largest share of the application segment in the Protein Expression market in 2021.
Based on application, the protein expression market is segmented into therapeutic, research and industrial applications. The therapeutic applications segment accounted for the largest share of the global protein expression market. An increase in protein-based research and the rising prevalence of chronic diseases across the globe are responsible for a large share of this market.
The Pharmaceutical and Biotechnology companies subsegment accounted for the largest share of the application segment in the Protein Expression market in 2021.
Based on the end users, the protein expression market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract development and manufacturing organizations (CROs and CDMOs), academic research institutes, and other end users. The pharmaceutical and biotechnology companies form the largest and fastest-growing end-user segment in this market owing to an increase in protein research to understand biological systems and the rising production of recombinant therapeutic proteins for disease treatment.
North America is the largest region and Asia Pacific is the fastest-growing region of the Protein Expression market in 2021.
Based on region, the protein expression market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2021, North America dominated the market, followed by Europe. Factors such as the growth in the biotechnology and pharmaceutical industries, the rising prevalence of chronic disorders, and an increase in protein-based therapeutics research investments are contributing to the large share of this market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period.
Key players in the Protein Expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Agilent Technologies Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Takara Bio Inc. (Japan), Bio-Rad Laboratories Inc. (US), Lonza Group AG (Switzerland), Promega Corporation (US), New England Biolabs (US), and Oxford Expression Technologies Ltd. (UK).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441